Reason: Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Distributed: Nationwide within the United StatesReason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Distributed: Product was distributed nationwide.Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Distributed: NationwideReason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Distributed: NationwideReason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Distributed: NationwideReason: Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the presence of Bacillus cereus.
Distributed: Product was distributed via the internet to consumers, retailers and to distributors who may have further distributed the product.Reason: Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.
Distributed: Nationwide in the U.S.Reason: Failed Tablet/Capsule Specification; oversized tablet found in a bottle
Distributed: nationwide within the United StatesReason: Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion
Distributed: Nationwide within the United StatesReason: CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.
Distributed: Nationwide in the USA and Puerto Rico